Forging the Future of Cell Therapy: Breakthrough CAR‑T Manufacturing in Stevenage

We are delighted to start 2026 by sharing groundbreaking life sciences innovation coming out of our Forge_Kn: Autolus Therapeutics site, delivered in joint venture with UBS.

We are proud to have designed the UK’s first purpose-built CAR-T cell manufacturing facility in Stevenage, supporting revolutionary CAR-T therapies that are now reversing previously incurable cancers.

Delighted to see the advancement of UK life sciences innovation and the delivery of real patient impact!

Read more - https://lnkd.in/e3hvAgmS